Torsemide
Torsemide structure
|
Common Name | Torsemide | ||
|---|---|---|---|---|
| CAS Number | 56211-40-6 | Molecular Weight | 348.420 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C16H20N4O3S | Melting Point | 163-164ºC | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS07 |
Signal Word | Warning | |
|
Determination of torasemide by fluorescence quenching method with some dihalogenated fluorescein dyes as probes.
Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 114 , 547-52, (2013) A novel fluorescence quenching method for the determination of torasemide (TOR) with some dihalogenated fluorescein dyes as fluorescence probes was developed. In acidulous medium, TOR could interact with some dihalogenated fluorescein dyes such as dichloroflu... |
|
|
Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?
J. Am. Coll. Cardiol. 61(14) , 1549-50, (2013)
|
|
|
Loop diuretics: comparison of torsemide, furosemide, and bumetanide.
Conn. Med. 60(6) , 343-5, (1996)
|
|
|
Should torsemide be the loop diuretic of choice in systolic heart failure?
Future Cardiol. 8(5) , 707-28, (2012) Furosemide is the most widely prescribed loop diuretic in the setting of systolic heart failure (HF), yet torsemide has been shown to have less inter- and intra-individual variation in bioavailability and a longer duration of action compared with furosemide. ... |
|
|
Torsemide: a pyridine-sulfonylurea loop diuretic.
Ann. Pharmacother. 29(4) , 396-402, (1995) To review the clinical pharmacology of torsemide and to compare it with currently available loop diuretics, particularly furosemide.An English-language MEDLINE search, 1985 to October 1994, was used to identify pertinent literature, including review articles.... |
|
|
Torsemide: a new loop diuretic.
Am. J. Health Syst. Pharm. 52(16) , 1771-80; quiz 1814-5, (1995) The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of torsemide are reviewed. Torsemide belongs to the pyridine-sulfonylurea class of loop diuretics. Its primary site of activity is the thick ascending limb o... |
|
|
Drug-induced photodermatitis in elderly nursing home residents.
J. Dtsch. Dermatol. Ges. 9(8) , 631-2, (2011)
|
|
|
Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy?
Eur. J. Heart Fail. 12(7) , 649-52, (2010)
|
|
|
Agents with antialdosterone properties should be the preferred diuretics for reducing hypertension related atrial fibrillation.
Eur. J. Intern. Med. 21(1) , 55, (2010)
|
|
|
A bioavailability/bioequivalence and pharmacokinetic study of two oral doses of torasemide (5 and 10 mg): prolonged-release versus the conventional formulation.
Clin. Exp. Pharmacol. Physiol. 36(5-6) , 469-77, (2009) 1. The main objective of the present study was to compare the bioavailability/bioequivalence of a new prolonged-release (PR) formulation of torasemide with an immediate-release (IR) formulation. In addition, we assessed the pharmacokinetics of both formulatio... |